Cannabis Law Report

AUGUST 26, 2019

DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. percent delta-9 THC threshold, is not a controlled substance, and a DEA registration is not required to grow or research it.

DEA 59

DEA Access Marijuana Programs 59

SpeedWeed

MAY 24, 2021

The Drug Enforcement Administration made a milestone announcement earlier this month with the news that the DEA will begin granting marijuana cultivation licenses to various third-party applicants, significantly expanding medical and scientific cannabis research in the United States.

DEA 52

DEA Cultivation Research and Development Marijuana 52

Veriheal

NOVEMBER 6, 2023

states and the District of Columbia currently have legal cannabis, medical or recreational. Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. To its credit, the state does seem to be making minor strides toward cannabis legalization lately.

Legalization 117

Legalization Recreational THC CBD 117

Veriheal

JANUARY 16, 2024

This occasion marks the first time that a federal agency has recommended rescheduling cannabis, and this could be the push the Drug Enforcement Administration (DEA) needs to finally make it happen. With cannabis’ current status as a Schedule I drug, it’s challenging for the federal government to push for nationwide legalization.

DEA 118

DEA Medicine Cannabis Legalization 118

MJ Business Attorneys

JUNE 29, 2018

Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

WeedAdvisor

AUGUST 28, 2019

As we reported earlier , marijuana experts were frustrated over the poor quality of cannabis grown at the government’s only legal marijuana facility at the University of Mississippi. Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. Dozens of Applications”. .

DEA 61

DEA Marijuana History THC 61

WeedAdvisor

JUNE 1, 2019

The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis.

DEA 55

DEA Marijuana History Cannabis 55

NORML

MARCH 1, 2019

.” The agency said that the policy change was necessary because the existing system provided “no clear legal pathway for commercial enterprises to produce marijuana for product development.” Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue.

DEA 166

DEA Research and Development Clinical Trials Marijuana 166

Veriheal

AUGUST 24, 2022

Colorado could legalize psychedelics. These include legalizing the possession, cultivation, use, and sharing of psychedelic components such as ibogaine , mescaline , DMT, psilocybin , and psilocin for adults over the age of 21. The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

MAY 10, 2022

Activists staged a demonstration outside of the Drug Enforcement Administration (DEA) headquarters in Virginia on Monday, demanding that the agency allow terminally ill patients to access psilocybin therapy. Marijuana Moment reports. DeaOutoftheway @RTTpsilocybin pic.twitter.com/1NJWt2cJWn. aeidinger) May 9, 2022.

DEA 52

DEA Therapy Access Patients 52

Cannabis Law Report

MARCH 30, 2022

NORML has long advocated for amending federal regulations so that federally-licensed scientists can directly access and assess the wide variety of cannabis products readily available in medical-use and adult-use state markets. Senate members in 2020 passed a similar version of S. 253 in the final weeks of the legislative session.

Legislation 95

Legislation Clinical Trials DEA Access 95

Marijuana Lawyer Blog

JANUARY 12, 2019

Plaintiffs in the lawsuit include a 12-year-old epilepsy patient, an 8-year-old Leigh’s syndrome patient, an Iraq war veteran and sufferer of post-traumatic stress disorder, a former NFL player who heads a hemp company hawking sports performance products and a non-profit that helps minorities get ahead in the legal cannabis market.

DEA 40

DEA Patients Epilepsy Medicine 40

Veriheal

MARCH 6, 2024

Department of Health and Human Services (HHS) recommended that the Drug Enforcement Agency (DEA) reshedule cannabis as a Schedule III substance in August of 2023. Let’s make one thing clear, rescheduling cannabis does not mean that it is suddenly federally legal. From One to Three: What Does This Change Actually Mean?

Research and Development 62

Research and Development DEA Chronic Pain Business 62

Cannabis Law Report

JUNE 16, 2022

NORML’s Political Director Morgan Fox added: “The fact that these interdiction efforts are growing — at great cost to the taxpayer — despite increasing momentum for legalization is a testament to the failure of federal prohibition and unnecessarily burdensome state regulatory policies. million plants were confiscated).

DEA 52

DEA Marijuana Programs Data 52

Cannabis Law Report

NOVEMBER 2, 2022

Drug Enforcement Administration and the legal team representing terminally ill patients petitioning for access to psilocybin-assisted therapy. In late September, the DEA denied an official petition requesting that the agency look into rescheduling psilocybin from Schedule I to Schedule II.

Microdosing 52

Microdosing DEA Therapy Access 52

Cannabis Law Report

MARCH 7, 2020

In its performance budget submission to Congress for fiscal year 2021, DEA gave an overview of its enforcement efforts and made predictions about future trends. Buried within the document is a subtle admission that giving consumers legal access to cannabis means that demand for marijuana products sourced from the illegal market decreases.

DEA 64

DEA THC Retail Access 64

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Canna Law Blog

AUGUST 16, 2022

As a refresher, the Drug Enforcement Administration (DEA) conducts the licensing process that enables researchers to gain access to cannabis product. The DEA still views cannabis as a controlled substance with “no known medical uses.” See: Not All Cannabis Reform is a Good Thing.).

DEA 66

DEA Access Cannabinoids Cannabis 66

Cannabis Law Report

JULY 28, 2022

Colorado could decriminalize the personal use and possession of certain psychedelic plants and fungi, including “magic mushrooms,” and create a Natural Medicine Access Program, according to a voter initiative on the November ballot. Oregon, two years ago, became the first state to legalize psilocybin with the approval of Measure 109.

Legalization 52

Legalization Decriminalization Food Safety 52

Veriheal

SEPTEMBER 13, 2022

The legal cannabis industry in the United States has slowly expanded over the last decade. With legalization, patients and consumers have more freedom in product choice, and many are turning to homegrown cannabis. With legalization, patients and consumers have more freedom in product choice, and many are turning to homegrown cannabis.

Cultivation 109

Cultivation Data DEA Dispensary 109

Cannabis Law Report

OCTOBER 4, 2021

However, this drug is not presently legally available, as it is classified as a Schedule I drug, severely restricted and regulated by the federal Controlled Substances Act. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment.

Therapy 52

Therapy Patients Law Clinical Trials 52

CannaMD

MAY 6, 2020

Is it okay to use legally purchased medical marijuana in states where it’s not legal? As attorney Allison Malsbury explains: From a legal perspective, it’s very cut and dried. In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening.

Hash 103

Hash Legalization Marijuana Concentrates 103

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.

DEA 111

DEA Hemp Cultivation Advocacy 111

NORML

JANUARY 15, 2020

He continued: “The fact of the matter is that legalization and regulation work. Eleven states regulate the adult use of marijuana and 33 states provide for medical cannabis access. Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA). Douglas Throckmorton, M.D., Volkow, M.D.,

Policy 193

Policy DEA Legislation Data 193

Cannabis Law Report

JANUARY 16, 2020

Now that Illinois has joined 10 other states and the District of Columbia in legalizing the recreational use and sale of marijuana, what can we expect from this new legislation? How was Illinois’ path to legalization different from other states? . What are some potential consequences of legalization? .

Law 59

Law Legalization DEA Marijuana 59

Cannabis Law Report

MAY 31, 2022

The short answer is: that current legal options (i.e. legal at the state level or the state and federal level) are limited. The Drug Enforcement Agency (DEA) currently has guidance published for those interested in petitioning for a religious exemption to the CSA. Federal Legal Status. Washington.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

SpeedWeed

MARCH 20, 2021

it focused entirely on individual liberties as the basis for cannabis legalization. Many advocacy groups fear that foreign corporations have already lined legislators’ pockets to ensure they can easily do business in the country, ultimately changing how legalization will impact consumer rights and rural and indigenous communities. .

Legalization 52

Legalization Legislation Advocacy DEA 52

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. The company initiated the first legal transfer (as deemed by federal law) to the U.S. Drug Enforcement Agency (DEA). territories. This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

The Blunt Truth

DECEMBER 29, 2023

Last year , I predicted there would be no federal cannabis legalization, but that perhaps states would legalize. Is predicting that there would be no federal legalization akin to shooting fish in a barrel? Virgin Islands legalized adult-use cannabis. Which brings us to April and some victories for legalization.

DEA 52

DEA Retail Legalization Food 52

Veriheal

NOVEMBER 11, 2023

Many states in the US have legalized cannabis, thirty-eight states to be exact. According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” Is Medical Cannabis Legal? tetrahydrocannabinol (THC) are legal.

Law 62

Law Chronic Pain Conditions Legislation 62

Cannabis Law Report

MAY 29, 2022

In 2020, Oregon became the first locale to decriminalize psilocybin and legalize it for therapeutic use on a statewide basis. 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. and Seattle, among other municipalities. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

FEBRUARY 28, 2022

This Essay analyzes the ethical, legal, and social implications of patenting these controversial substances. Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. Patents on Psychedelics: The Next Legal Battlefront of Drug Development. 19 × 19.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

NewsMunchies

NOVEMBER 12, 2021

As the cannabis industry continues to grow and evolve with legalization achieved in many parts of the world, we’re seeing an increase in activity related to another substance that will hopefully be removed from the list of controlled substances – psilocybin. We know such categorization is baseless and false. Let’s put science first.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

Canna Law Blog

DECEMBER 6, 2022

Unless you’ve been living under a rock, you know that two of the biggest problems for the cannabis industry overall are access to financial institutions and I.R.C. DOJ “issues” The SAFE Banking Act neither legalizes cannabis nor reschedules it on the Controlled Substances Act. Section 280E. Technical comments.

Banking 80

Banking Compliance Compliance State Laws 80

Canna Law Blog

NOVEMBER 27, 2021

So according to the DEA, its abuse potential is high and it has no medical use. Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” Psychedelic Decriminalization and Legalization Roundup.

Therapy 87

Therapy Clinical Trials DEA Microdosing 87

Cannabis Law Report

NOVEMBER 4, 2021

The President could pursue the appointment of agency officials who favor descheduling, or use executive orders to direct DEA, HHS, and FDA to consider administrative descheduling of marijuana. The CRS specifically addresses the Executive Branch’s abilities to remove marijuana from the Controlled Substances Act: . We’re beyond that.”.

DEA 52

DEA Marijuana Decriminalization Data 52

The Blunt Truth

JANUARY 16, 2020

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. Pretty much every news outlet that covers cannabis has a piece on this, Marijuana Business Daily has a nice round-up that’s free to access. Their plan is to try again in 2022.

Decriminalization 60

Decriminalization DEA Hemp Legislation 60